Indatuximab ravtansine, CAS 1238517-16-2

Product Description: Indatuximab ravtansine (BT-062) is an antibody-drug conjugate (ADC) (Antibody-Drug Conjugates (ADCs)) based on a murine/human chimeric form of B-B4 (specific for CD138), linked to the maytansinoid agent DM4 by disulphide bonds. Indatuximab ravtansine shows anti-tumor activities[1].

Applications: Cancer-programmed cell death

Formula: N/A

References: [1]Kurt Schönfeld, et al. Indatuximab ravtansine (BT062) combination treatment in multiple myeloma: pre-clinical studies. J Hematol Oncol. 2017 Jan 11;10(1):13.

CAS Number: 1238517-16-2

Molecular Weight: N/A

Research Area: Cancer

Solubility: 10 mM in DMSO

Target: Antibody-Drug Conjugates (ADCs);Bacterial

• Artikelnummer: MEXHY-141607-0
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-141607-0
• Verpackungseinheit: Get quote
• Mengeneinheit: STK